Bio-Rad Labs (BIO) Tops Q2 EPS by 37c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $385.12 +1.08%
EPS Growth %: -1.3%
Financial Fact:
Cost of goods sold: 236.55M
Today's EPS Names:
GFL, NHTC, SKHY, More
EPS Growth %: -1.3%
Financial Fact:
Cost of goods sold: 236.55M
Today's EPS Names:
GFL, NHTC, SKHY, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $1.64, $0.37 better than the analyst estimate of $1.27. Revenue for the quarter came in at $575.9 million versus the consensus estimate of $548.43 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Plexus Corp (PLXS) Tops Q4 EPS by 29c; offers guidance
- American Electric Power (AEP) Tops Q3 EPS by 21c; Offers Guidance
- Quad/Graphics (QUAD) Misses Q3 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
